Medivolve Inc. MEDVF
OTC PK
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 46.40% | 32.15% | 7.75% | -410.76% | -1,206.13% |
| Total Depreciation and Amortization | -103.39% | -94.65% | -77.32% | -57.15% | -21.14% |
| Total Amortization of Deferred Charges | -24.86% | -24.86% | 99.37% | 99.37% | 59.18% |
| Total Other Non-Cash Items | -34.72% | -15.26% | -78.32% | -65.81% | -28.83% |
| Change in Net Operating Assets | 7.46% | -90.42% | 106.08% | 129.06% | 113.85% |
| Cash from Operations | 91.07% | -132.82% | -146.13% | -115.12% | -205.63% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -39.48% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 41.42% | -- |
| Total Debt Issued | -100.00% | -- | 2,714.38% | -63.02% | -63.02% |
| Total Debt Repaid | 97.79% | 19.91% | -95.54% | -63.52% | -364.60% |
| Issuance of Common Stock | -- | -- | -100.00% | -100.00% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 96.65% | 83.89% | 16.81% | -138.94% | -151.04% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 89.13% | -158.81% | -173.36% | -122.66% | -182.14% |